Year : 2015 | Volume
: 1 | Issue : 1 | Page : 65--68
Gajender Dubey1, Derek Cyr2, Ambuj Roy1,
1 Department of Cardiology, Cardiothoracic Centre, All India Institute of Medical Sciences, New Delhi, India
2 Duke Clinical Research Institute, Durham, North Carolina, USA
Dr. Ambuj Roy
Department of Cardiology, Cardiothoracic Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029
|How to cite this article:|
Dubey G, Cyr D, Roy A. Journal review.J Pract Cardiovasc Sci 2015;1:65-68
|How to cite this URL:|
Dubey G, Cyr D, Roy A. Journal review. J Pract Cardiovasc Sci [serial online] 2015 [cited 2021 Jun 18 ];1:65-68
Available from: https://www.j-pcs.org/text.asp?2015/1/1/65/157576
Martin O'Donnell, M.B., Ph.D., Andrew Mente, Ph.D., et al. for the PURE investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014;371:612-23.
Sodium is the most important extracellular cation regulating extracellular fluid volumeSodium intake is known to be a modifiable determinant of hypertensionModest association between higher levels of sodium intake and higher blood pressure was seen in the INTERSALT study Guidelines for prevention of cardiovascular disease recommend sodium intake of 1.5−2.4 g/day There is a lack of definite evidence of benefit of this recommendationSeveral small prospective cohort studies have shown inconsistent association between sodium intake and cardiovascular events and death.
The primary objective of this study is to determine the association between estimated daily sodium and potassium intake with a composite outcome of death from any cause and major cardiovascular eventsMajor cardiovascular events included death from cardiovascular causes, stroke, myocardial infarction, or heart failure
Large scale epidemiological prospective cohort study156,424 persons, 35−70 years of age residing in 628 urban and rural communities in 17 low, middle and high-income countries were screenedFinal study sample consisted of 102,216 participants with a valid baseline fasting morning urine sample42% participants were from China.
UrinalysisMorning fasting midstream urine samples were collected from each participant and frozen at −20°C to −70°CUrine samples shipped in ambient packaging with STP-250 to regional research laboratories where the urinalysis was done to determine spot urinary sodium and potassium contentKawasaki formula was used to estimate 24-h urinary sodium and potassium excretion The estimates were used as surrogates for daily sodium and potassium intakeData collectionQuestionnaire was used for Information on personal medical history and use of prescription medicationStandardized case-report forms were used to capture data on major cardiovascular events and death during follow-upFollow-up was initiated in 2008 and completed by 2013At least one, and up to three visits were attempted at each sitePrespecified definitions of end points were used for event monitoring.
Chi-square test for categorical variables and analysis of variance for continuous variablesRestricted cubic spline plots: To explore shape of the association between the estimated sodium and potassium excretion and the outcomes. The "spline" is a flexible strip of metal commonly used by drafters to draw curved lines. Cubic spline plots are useful tools to model nonlinear relationshipsThree models adjusted for various variables were used to determine associationsArray approach sensitivity analysis and propensity score matched sensitivity analyses were also performed. Sensitivity analysis is the study of how the uncertainty in the output of a mathematical model can be attributed to different sources of uncertainty in its input variables. Taking an example from any budgeting process: There are always uncertain variables such as inflation rates, future taxes, interest rates, etc., Sensitivity analysis estimates what will be the effect on the budget and by how much by the change in each of these variables. In many studies, two study groups can be significantly different from each other, and their differences cannot be attributed to an intervention effect. Propensity score matched analysis methods offer a way to balance groups by matching treatment and control units based on a set of covariatesReference levels of usual intake were 4−5.99 g/day for sodium and <1.5 g/day for potassium.
Mean estimated 24-h sodium excretion was 4.93 g and mean estimated 24-h potassium excretion was 2.12 gMean duration of follow-up was 3.7 yearsFollow-up was completed for 95% of the participantsPrimary composite outcome: 3317 participants (3.3%), 1976 deaths (650 cardiovascular causes), 857 myocardial infarction, 872 stroke, 261 heart failureMean systolic and diastolic blood pressures were higher among participants with a higher estimated sodium excretion (P < 0.001)Participants may have had more than one cardiovascular event.
Sodium excretion and risk of primary outcome
Excretion of 7.00 g/day compared with 4.00−5.99 g/day (reference range):Increased risks of the primary composite outcome (odds ratio, 1.15; 95% confidence interval [CI], 1.02−1.30).Increased risk of death from any cause (odds ratio, 1.25; 95% CI, 1.07−1.48)Increased risk of major cardiovascular event (odds ratio, 1.16; 95% CI, 1.01−1.34), death from cardiovascular causes (odds ratio, 1.54; 95% CI, 1.21−1.95), and stroke resulting in death or hospitalization (odds ratio, 1.29; 95% CI, 1.02−1.63) on multivariable analysis.The association was attenuated and became nonsignificant after adjustment for hypertension for all variables except death from any causeEstimated excretion of <3.00 g/day compared with excretion of 4.00−5.99 g/day:Increased risks of the primary composite outcome (odds ratio, 1.27; 95% CI, 1.12−1.44), death from any cause (odds ratio, 1.38; 95% CI, 1.15−1.66), a major cardiovascular event (odds ratio, 1.30; 95% CI, 1.13−1.50), death from cardiovascular causes (odds ratio, 1.77; 95% CI, 1.36−2.31), and stroke resulting in death or hospitalization (odds ratio, 1.37; 95% CI, 1.07−1.76)Associations remained significant after adjustment for blood pressure or prior diagnosis of hypertension.
Estimated potassium excretion and risk of outcomes
Reduction in the risks of death and cardiovascular events with higher potassium excretion as compared to excretion of <1.50 g/dayNo evidence of an interaction between estimated potassium and sodium excretion with respect to the primary composite outcome (P = 0.55).
Group and sensitivity analyses
Hypertension at baseline significantly modified the association between a high estimated sodium excretion and the composite outcome (P = 0.02 for interaction)No other significant subgroup interactions were thereFindings from the sodium and potassium analyses were not affected by exclusion of participants with cardiovascular disease (at baseline) or cancer (at baseline or follow-up) or those who had events in the 1 st year of follow-up did not materially affect thePropensity-score - matched analysis21,220 participantsLow estimated sodium excretion (<3.00 g/day), as compared with a moderate level (3.00−5.99 g/day), was associated with an increased risk of the composite outcome (odds ratio, 1.26; 95% CI, 1.09−1.46)Similar results were seen in analysis of 40,618 participants, with high estimated sodium excretion (>6.00 g/day), associated with an increased risk of the composite outcome (odds ratio, 1.19; 95% CI, 1.06−1.34).
Large international prospective cohort study reflecting patterns of sodium and potassium intake in a diverse population groupsInvestigated association between estimated sodium and potassium excretion and composite of death and cardiovascular outcomesShows that the global salt consumptions are significantly higher than the currently recommended intake of 1.5−2.4 g/day, with only small percentage (4%) consuming the recommended amountFindings suggest lowest risk of death and cardiovascular events with moderate salt intakeBoth higher and lower intake were associated with increased risk of adverse outcomesAssociation between high estimated sodium excretion and increased risk was amplified by the presence of hypertensionThis risk attenuated after adjustment for blood pressure, suggesting effects of sodium intake on blood pressureAssociation between a low estimated sodium excretion and increased risk were unaffected by adjustment for blood pressureGuideline recommendations of low salt intake are based on short-term clinical studies showing reduction in blood pressure with low sodium and assuming a linear relationship between blood pressure and adverse outcomesAssumed no unsafe lower limit of sodium intakeLow sodium intake may be harmful as low sodium levels may lead to inappropriate activation of renin-angiotensin-aldosterone system leading to deleterious effectsFew prior studies showed increased risk with low sodium intake, however, these included high-risk patients raising possibility of reverse causation Majority of patients included in this study were free of major cardiovascular diseaseExclusion of cancer, cardiovascular disease, diabetes, those with events in 2 years didn't cause alteration in resultsAlthough reverse causation cannot totally be ruled out but results do suggest that low sodium intake may not be completely innocuousHigher potassium excretion proved to be a negative risk factorMay act by reducing blood pressureFurthermore, there was interaction between sodium and potassium excretion with accentuated rise in blood pressure with increased sodium excretion in the presence of low potassium excretionEffects of potassium were attenuated after adjustment of fruit and vegetable intake.
Most important limitation of this study is an estimation of daily sodium and potassium excretion from single morning urinary sample instead of using the more reliable method of multiple 24-h urine sample analysisFurthermore, the Kawasaki formula for estimation of 24-h potassium excretion is not well validatedSampling was not random and may not be representative of the general populationPossibility of unmeasured confounding variables remains highInability to completely rule out reverses causationProvides an epidemiological comparison of groups consuming different amounts of salt, not the effect of reducing salt intakeHigh-risk patients with established cardiovascular disease were not included, so the findings are not applicable to such patients.
Another study (SALT)  from same sample population studied the association between sodium and potassium excretion and blood pressure levels, showing nonlinear relationship with most pronounced effects in persons consuming high-sodium diets, persons with hypertension, and older personsThe results of PURE study should not be considered as the final verdict regarding the optimal amount of salt consumption as there is an ample amount of conflicting evidence alsoThe NUTRICODE  study published simultaneously, although based on statistical modeling, showed that sodium consumption higher than 2 g/day contributes to 1.65 million cardiovascular deaths annually worldwideThe debate regarding optimal salt intake continues as American Heart Association has released a statement mentioning this study as an observational study attempting to link dietary sodium intake with subsequent cardiovascular eventsThe editorial  on this study draws attention to the biggest drawback of the study, that is, the method of estimation of 24-h sodium and potassium excretion and on lack of interventional component to assess the direct effects of altering sodium and potassium intake on blood pressure and cardiovascular disease outcomes, hence making it impossible to establish causalityThe editorial also stresses on the need of a large randomized controlled trial to address these issues.
Estimated sodium intake of 3-6 g/day is associated with lower risk of death and cardiovascular outcomes compared to higher or lower intakePotassium intake higher than 1.5 g/day is associated with lower risk of adverse cardiovascular outcomesBlanket recommendation of low sodium intake may not be beneficial for the general populationRecommendations in high-risk groups need to be individualized.Results from this study can only be considered as hypothesis generating, and a randomized controlled trial is required to prove or disprove the utility of low salt intakeFurthermore, there is a need for standardized and well-validated technique for measurement of daily sodium and potassium intake as estimation of these variables from a single urinary sample is unlikely to be accurate.
|1||Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319-28.|
|2||Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129 25 Suppl 2:S76-99.|
|3||Kawamura M, Kusano Y, Takahashi T, Owada M, Sugawara T. Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs. Hypertens Res 2006;29:397-402.|
|4||O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011;306:2229-38.|
|5||Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 2014;371:601-11.|
|6||Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med 2014;371:624-34.|
|7||Oparil S. Low sodium intake - Cardiovascular health benefit or risk? N Engl J Med 2014;371:677-9.|